Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Novel agents for the treatment of acute myeloid leukemia in the older patient.

Baer MR, Gojo I.

J Natl Compr Canc Netw. 2011 Mar;9(3):331-5.

PMID:
21393442
2.

Profile of sapacitabine: potential for the treatment of newly diagnosed acute myeloid leukemia in elderly patients.

Lim MY, Jamieson K.

Clin Interv Aging. 2014 May 6;9:753-62. doi: 10.2147/CIA.S39558. eCollection 2014. Review.

3.

Clofarabine plus low-dose cytarabine followed by clofarabine plus low-dose cytarabine alternating with decitabine in acute myeloid leukemia frontline therapy for older patients.

Faderl S, Ravandi F, Huang X, Wang X, Jabbour E, Garcia-Manero G, Kadia T, Ferrajoli A, Konopleva M, Borthakur G, Burger J, Feliu J, Kantarjian HM.

Cancer. 2012 Sep 15;118(18):4471-7. doi: 10.1002/cncr.27429. Epub 2012 Jan 26.

4.

New agents for the treatment of AML recent study findings.

Gore SD.

Clin Adv Hematol Oncol. 2008 Nov;6(11):6-8. No abstract available.

PMID:
19205109
5.

Clofarabine in the treatment of newly diagnosed acute myeloid leukemia in older adults.

Tran H, Yang D.

Ann Pharmacother. 2012 Jan;46(1):89-96. doi: 10.1345/aph.1Q295. Epub 2011 Dec 13. Review.

PMID:
22170975
6.

Novel and emerging drugs for acute myeloid leukemia: pharmacology and therapeutic activity.

Robak T, Szmigielska-Kapłon A, Pluta A, Grzybowska-Izydorczyk O, Wolska A, Czemerska M, Wierzbowska A.

Curr Med Chem. 2011;18(5):638-66. Review.

PMID:
21182488
7.

Sapacitabine in the treatment of acute myeloid leukemia.

Norkin M, Richards AI.

Expert Rev Anticancer Ther. 2015;15(11):1261-6. doi: 10.1586/14737140.2015.1102064. Epub 2015 Nov 2.

PMID:
26523431
8.

European development of clofarabine as treatment for older patients with acute myeloid leukemia considered unsuitable for intensive chemotherapy.

Burnett AK, Russell NH, Kell J, Dennis M, Milligan D, Paolini S, Yin J, Culligan D, Johnston P, Murphy J, McMullin MF, Hunter A, Das-Gupta E, Clark R, Carr R, Hills RK.

J Clin Oncol. 2010 May 10;28(14):2389-95. doi: 10.1200/JCO.2009.26.4242. Epub 2010 Apr 12.

PMID:
20385984
9.

Clofarabine does not negatively impact the outcomes of patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation.

Mathisen MS, Kantarjian H, Jabbour E, Garcia-Manero G, Ravandi F, Faderl S, Borthakur G, Cortes JE, Quintás-Cardama A.

Clin Lymphoma Myeloma Leuk. 2013 Apr;13(2):139-43. doi: 10.1016/j.clml.2012.11.004. Epub 2012 Dec 29.

10.

Clofarabine doubles the response rate in older patients with acute myeloid leukemia but does not improve survival.

Burnett AK, Russell NH, Hunter AE, Milligan D, Knapper S, Wheatley K, Yin J, McMullin MF, Ali S, Bowen D, Hills RK; UK National Cancer Research Institute AML Working Group.

Blood. 2013 Aug 22;122(8):1384-94. doi: 10.1182/blood-2013-04-496596. Epub 2013 Jul 9.

11.

Phase II study of clofarabine monotherapy in previously untreated older adults with acute myeloid leukemia and unfavorable prognostic factors.

Kantarjian HM, Erba HP, Claxton D, Arellano M, Lyons RM, Kovascovics T, Gabrilove J, Craig M, Douer D, Maris M, Petersdorf S, Shami PJ, Yeager AM, Eckert S, Abichandani R, Faderl S.

J Clin Oncol. 2010 Feb 1;28(4):549-55. doi: 10.1200/JCO.2009.23.3130. Epub 2009 Dec 21.

PMID:
20026805
12.

New agents: great expectations not realized.

Lancet JE.

Best Pract Res Clin Haematol. 2013 Sep;26(3):269-74. doi: 10.1016/j.beha.2013.10.007. Epub 2013 Oct 16. Review.

PMID:
24309529
13.

Clofarabine ± fludarabine with once daily i.v. busulfan as pretransplant conditioning therapy for advanced myeloid leukemia and MDS.

Andersson BS, Valdez BC, de Lima M, Wang X, Thall PF, Worth LL, Popat U, Madden T, Hosing C, Alousi A, Rondon G, Kebriaei P, Shpall EJ, Jones RB, Champlin RE.

Biol Blood Marrow Transplant. 2011 Jun;17(6):893-900. doi: 10.1016/j.bbmt.2010.09.022. Epub 2010 Oct 11.

14.

New drugs in acute myeloid leukemia.

Estey E.

Semin Oncol. 2008 Aug;35(4):439-48. doi: 10.1053/j.seminoncol.2008.04.014. Review.

PMID:
18692694
15.

Conventional chemotherapy or hypomethylating agents for older patients with acute myeloid leukaemia?

Ferrara F.

Hematol Oncol. 2014 Mar;32(1):1-9. doi: 10.1002/hon.2046. Epub 2013 Mar 20. Review.

PMID:
23512815
16.

Feasibility of clofarabine cytoreduction followed by haploidentical hematopoietic stem cell transplantation in patients with relapsed or refractory advanced acute leukemia.

Tischer J, Stemmler HJ, Engel N, Hubmann M, Fritsch S, Prevalsek D, Schulz C, Zoellner AK, Bücklein V, Hill W, Ledderose G, Hausmann A.

Ann Hematol. 2013 Oct;92(10):1379-88. doi: 10.1007/s00277-013-1862-6. Epub 2013 Aug 9.

PMID:
23928857
17.

The role of Clofarabine in the treatment of adults with acute myeloid leukemia.

Fozza C.

Crit Rev Oncol Hematol. 2015 Mar;93(3):237-45. doi: 10.1016/j.critrevonc.2014.10.009. Epub 2014 Oct 22. Review.

PMID:
25457773
18.

Has there been progress in the treatment of older patients with acute myeloid leukemia?

Erba HP.

Best Pract Res Clin Haematol. 2010 Dec;23(4):495-501. doi: 10.1016/j.beha.2010.09.012. Epub 2010 Nov 1. Review.

PMID:
21130413
19.

Potential role of novel nucleoside analogs in the treatment of acute myeloid leukemia.

Faderl S, Gandhi V, Kantarjian HM.

Curr Opin Hematol. 2008 Mar;15(2):101-7. doi: 10.1097/MOH.0b013e3282f46e94. Review.

PMID:
18300755
20.

Acute myeloid leukemia in the elderly: conventional and novel treatment approaches.

Craig CM, Schiller GJ.

Blood Rev. 2008 Jul;22(4):221-34. doi: 10.1016/j.blre.2008.03.002. Epub 2008 Apr 22. Review.

PMID:
18433953

Supplemental Content

Support Center